Medical Consumables & Equipment Providers in China: Key Takeaways from the National Pharmaceutical Trading Fair

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- As the global healthcare industry continues to evolve, ...
Investor's Business Daily on MSN

China biotech lights up. US stocks prepare for a new powerhouse.

U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...
Fierce Pharma

Fierce Pharma Asia—Gilead's synthetic lethality deal; A Tokyo biotech IPO; Novo’s Ozempic China sales dip

Gilead has penned a potential $1.5 billion synthetic lethality deal with a Chinese biotech. A cell therapy company could end ...

Analysis - China biotech licensing boom to hit record in 2026 as pipeline swells

By Kane Wu and Andrew Silver HONG KONG/SHANGHAI, Feb 13 (Reuters) - Global drugmakers are stepping up their search for ...

China’s Hospital Disinfectant Supplies: A Key Highlight at the National Pharmaceutical Trading Fair

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- As global healthcare systems continue to prioritize ...

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug applications process ...

China’s Drug Industry Moves From ‘Follower To Leader’

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Fierce Biotech

Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse

Gilead has secured another synthetic lethal therapy, handing over $80 million upfront for the global rights to a clinic-ready cancer drug from China’s Genhouse Bio. | Gilead has secured another ...

How To Select China Standard-Compliant Pharmaceutical Wastewater Treatment Solutions For Industrial Plants

The Evolving Landscape of Pharmaceutical Wastewater Management The global pharmaceutical industry is currently navigating a period of significant transition, where environmental compliance has moved ...
NBC Connecticut

It's not just AI — China's quickly gaining an edge over the U.S. in biotech

BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China's rapid rise in biotechnology, especially for drug and agricultural development. Stream ...